USD 4.75
↑ 0.16 (3.49%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| CLVT | 3.5 | 2.2 | -29.8 | -23.4 | -23.6 | -26.8 | -80.1 | -71.9 | -50.5 | -50.5 |
| S&P 500 | 0.0 | 0.1 | 2.9 | 10.1 | 14.6 | 35.7 | 27.8 | 93.4 | 193.5 | 33792.3 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | CLVT |
| name | Clarivate Plc |
| price | 4.75 |
| changes percentage | 3.49 |
| change | 0.16 |
| day low | 4.61 |
| day high | 4.88 |
| year high | 9.61 |
| year low | 4.43 |
| market cap | 3374419000 |
| price avg 50 | 6.47 |
| price avg 200 | 6.72 |
| exchange | NYSE |
| volume | 7363767 |
| avg volume | 4242225 |
| open | 4.62 |
| previous close | 4.59 |
| eps | -1.98 |
| pe | -2.40 |
| earnings announcement | 2025-02-25T05:00:00.000+0000 |
| shares outstanding | 710404000 |
| timestamp | 2024-11-13 21:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001764046 | |||
| revenue | 2628800000 | 2659800000 | -1.17 |
| gross profit | 1722400000 | 1705800000 | 0.97 |
| gross profit ratio | 0.66 | 0.64 | 2.16 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 2457100000 | 1115600000 | 120.25 |
| interest income | 0 | 270300000 | -100.00 |
| interest expense | 293700000 | 270300000 | 8.66 |
| ebitda | -85900000 | 1300700000 | -106.60 |
| ebitdaratio | -0.03 | 0.49 | -106.68 |
| operating income | -734700000 | -3925600000 | 81.28 |
| operating income ratio | -0.28 | -1.48 | 81.06 |
| net income | -911200000 | -3960200000 | 76.99 |
| net income ratio | -0.35 | -1.49 | 76.72 |
| eps | -1.47 | -5.86 | 74.91 |
Revenue Growth: revenue decreased to 2,629 million in 2023 from 2,660 million in 2022 representing a change of -1.17%. This indicates a sales shrinking, which is a negative sign for the company.
Operating Expenses: Operating Expenses increased to 2,457 million in 2023 from 1,116 million in 2022 representing a change of 120.25%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -86 million in 2023 from 1,301 million in 2022 representing a change of -106.6%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Gross Profit: Gross Profit increased to 1,722 million in 2023 from 1,706 million in 2022 representing a change of 0.97%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Income: Operating income increased to -735 million in 2023 from -3,926 million in 2022 representing a change of 81.28%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to -911 million in 2023 from -3,960 million in 2022 representing a change of 76.99%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to -1.47 in 2023 from -1.47 in 2022 representing a change of 74.91%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001764046 | |||
| revenue | 622200000 | 650300000 | -4.32 |
| gross profit | 412100000 | 252300000 | 63.34 |
| gross profit ratio | 0.66 | 0.39 | 70.71 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 390400000 | 185200000 | 110.80 |
| interest income | 0 | 0 | NaN |
| interest expense | 72200000 | 71100000 | 1.55 |
| ebitda | 198900000 | 251500000 | -20.91 |
| ebitdaratio | 0.32 | 0.39 | -17.34 |
| operating income | 21700000 | 67099999 | -67.66 |
| operating income ratio | 0.03 | 0.1 | -66.20 |
| net income | -65600000.0 | -304300000 | 78.44 |
| net income ratio | -0.11 | -0.47 | 77.47 |
| eps | -0.09 | -0.44 | 79.25 |
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001764046 | |||
| total assets | 12706800000 | 13944900000 | -8.88 |
| total liabilities | 6714500000 | 7132400000 | -5.86 |
| total equity | 5992300000 | 6812500000 | -12.04 |
| cash and cash equivalents | 370700000 | 348800000 | 6.28 |
| short term investments | 4100000 | 2300000 | 78.26 |
| long term investments | 17700000 | 47200000 | -62.50 |
| total current assets | 1462200000 | 1395200000 | 4.80 |
| total non current assets | 11244600000 | 12549700000 | -10.40 |
| total current liabilities | 1600000000 | 1559800000 | 2.58 |
| total non current liabilities | 5114500000 | 5572600000 | -8.22 |
| common stock | 11740500000 | 11744700000 | -0.04 |
| retained earnings | -6645500000 | -5658900000 | -17.43 |
| total debt | 4808700000 | 5104600000 | -5.80 |
Total Assets: Total Assets decreased to 12,707 million in 2023 from 13,945 million in 2022 representing a change of -8.88%. Suggesting a decrease in asset holdings.
Total Equity: Total Equity decreased to 5,992 million in 2023 from 6,812 million in 2022 representing a change of -12.04%. This indicates a decrease in shareholders' equity.
Total Current Liabilities: Total Current Liabilities increased to 1,600 million in 2023 from 1,560 million in 2022 representing a change of 2.58%. This indicates a higher short-term debt burden.
Common Stock: Common Stock decreased to 11,740 in 2023 from 11,745 in 2022 representing a change of -0.04%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -6,646 million in 2023 from -5,659 million in 2022 representing a change of -17.43%. This indicates an accumulated losses.
Total Liabilities: Total Liabilities decreased to 6,714 million in 2023 from 7,132 million in 2022 representing a change of -5.86%. This indicates a decrease in overall liabilities.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 371 million in 2023 from 349 million in 2022 representing a change of 6.28%. This indicates an increase in available liquid assets.
Short Term Investments: Short Term Investments increased to 4 million in 2023 from 2 million in 2022 representing a change of 78.26%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 1,462 million in 2023 from 1,395 million in 2022 representing a change of 4.8%. This indicates a better liquidity position.
Total Debt: Total Debt decreased to 4,809 million in 2023 from 5,105 million in 2022 representing a change of -5.8%. This indicates a reduction in overall debt burden.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001764046 | |||
| total assets | 12030600000 | 12077700000 | -0.39 |
| total liabilities | 6517100000 | 6473100000 | 0.68 |
| total equity | 5513500000 | 5604600000 | -1.63 |
| cash and cash equivalents | 388500000 | 376400000 | 3.21 |
| short term investments | 0 | 0 | NaN |
| long term investments | 7400000 | 26000000 | -71.54 |
| total current assets | 1339100000 | 1334800000 | 0.32 |
| total non current assets | 10691500000 | 10742900000 | -0.48 |
| total current liabilities | 1525600000 | 1485100000 | 2.73 |
| total non current liabilities | 4991500000 | 4988000000 | 0.07 |
| common stock | 13069000000 | 13157700000 | -0.67 |
| retained earnings | -7121700000 | -7056100000 | -0.93 |
| total debt | 4712500000 | 4731300000 | -0.40 |
Total Assets: Total Assets decreased to 12,031 million in 2024Q3 from 12,078 million in 2024Q2 representing a change of -0.39%. Suggesting a decrease in asset holdings.
Total Liabilities: Total Liabilities increased to 6,517 million in 2024Q3 from 6,473 million in 2024Q2 representing a change of 0.68%. This indicates an increase in overall liabilities.
Total Equity: Total Equity decreased to 5,514 million in 2024Q3 from 5,605 million in 2024Q2 representing a change of -1.63%. This indicates a decrease in shareholders' equity.
Total Current Liabilities: Total Current Liabilities increased to 1,526 million in 2024Q3 from 1,485 million in 2024Q2 representing a change of 2.73%. This indicates a higher short-term debt burden.
Common Stock: Common Stock decreased to 13,069 in 2024Q3 from 13,158 in 2024Q2 representing a change of -0.67%. This indicates a decrease in ownership interest.
Retained Earnings: Retained Earnings decreased to -7,122 million in 2024Q3 from -7,056 million in 2024Q2 representing a change of -0.93%. This indicates an accumulated losses.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 388 million in 2024Q3 from 376 million in 2024Q2 representing a change of 3.21%. This indicates an increase in available liquid assets.
Total Current Assets: Total Current Assets increased to 1,339 million in 2024Q3 from 1,335 million in 2024Q2 representing a change of 0.32%. This indicates a better liquidity position.
Total Debt: Total Debt decreased to 4,712 million in 2024Q3 from 4,731 million in 2024Q2 representing a change of -0.4%. This indicates a reduction in overall debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0001764046 | |||
| net change in cash | 13900000 | -230800000 | 106.02 |
| operating cash flow | 744200000 | 509300000 | 46.12 |
| free cash flow | 501700000 | 306400000 | 63.74 |
| capital expenditure | -242500000 | -202900000 | -19.52 |
| depreciation and amortization | 708300000 | 710500000 | -0.31 |
| deferred income tax | -78400000 | -54300000 | -44.38 |
| stock based compensation | 109000000 | 93900000 | 16.08 |
| accounts payables | 41200000 | -24000000 | 271.67 |
| inventory | 0 | -210300000 | 100.00 |
| acquisitions net | 5100000 | 260200000 | -98.04 |
| investments in property plant and equipment | -242500000 | -202900000 | -19.52 |
| net cash used for investing activites | -237400000 | 57300000 | -514.31 |
| debt repayment | -301000000 | 0 | NaN |
| common stock issued | 0 | 5700000 | -100.00 |
| common stock repurchased | -100000000 | -175000000 | 42.86 |
| dividends paid | -75500000 | -75400000 | -0.13 |
| net cash used provided by financing activities | -496500000 | -759200000 | 34.60 |
| cash at end of period | 370700000 | 356800000 | 3.90 |
| accounts receivables | -25500000 | -28300000 | 9.89 |
| cash at beginning of period | 356800000 | 587600000 | -39.28 |
Net Change in Cash: Net Change in Cash increased to 14 million in 2023 from -231 million in 2022 representing a change of 106.02%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 744 million in 2023 from 509 million in 2022 representing a change of 46.12%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 502 million in 2023 from 306 million in 2022 representing a change of 63.74%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -242 million in 2023 from -203 million in 2022 representing a change of -19.52%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation increased to 109 million in 2023 from 94 million in 2022 representing a change of 16.08%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 41 million in 2023 from 24 million in 2022 representing a change of 271.67%. This indicates that the company has increased its outstanding obligations to its suppliers.
Accounts Receivables: Accounts Receivables increased to -26 in 2023 from -28 million in 2022 representing a change of 9.89%. This suggests that the company is less capable of collecting payments from its customers.
Dividends Paid: Dividends Paid decreased to -76 million in 2023 from -75 million in 2022 representing a change of -0.13%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
| 2024Q3 | 2024Q2 | Q/Q change % | |
|---|---|---|---|
| 0001764046 | |||
| operating cash flow | 203100000 | 126000000 | 61.19 |
| free cash flow | 126500000 | 60100000 | 110.48 |
| capital expenditure | -76600000 | -65900000 | -16.24 |
| depreciation and amortization | 177200000 | 184400000 | -3.90 |
| deferred income tax | -4200000 | -24600000 | 82.93 |
| stock based compensation | 15100000 | 18900000 | -20.11 |
| accounts receivables | 45000000 | 28400000 | 58.45 |
| accounts payables | -4300000 | 25100000 | -117.13 |
| inventory | 0 | 0 | NaN |
| acquisitions net | 4300000 | -36300000 | 111.85 |
| investments in property plant and equipment | -76600000 | -65900000 | -16.24 |
| net cash used for investing activites | -91500000.0 | -102200000 | 10.47 |
| debt repayment | -5700000 | 0 | NaN |
| common stock issued | 0 | 0 | NaN |
| common stock repurchased | -100000000 | -1300000 | -7,592.31 |
| dividends paid | 0 | -18800000 | 100.00 |
| net cash used provided by financing activities | -109900000 | -25400000 | -332.68 |
| net change in cash | 12100000 | 14600000 | -17.12 |
| cash at end of period | 388500000 | 376400000 | 3.21 |
| cash at beginning of period | 376400000 | 361800000 | 4.04 |
Net Change in Cash: Net Change in Cash decreased to 12 million in 2024Q3 from 15 million in 2024Q2 representing a change of -17.12%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.
Deferred Income Tax: Deferred Income Tax increased to -4 million in 2024Q3 from -25 million in 2024Q2 representing a change of 82.93%. This indicates that the company's tax liability for future periods has increased.
Accounts Receivables: Accounts Receivables increased to 45 in 2024Q3 from 28 million in 2024Q2 representing a change of 58.45%. This suggests that the company is less capable of collecting payments from its customers.
Operating Cash Flow: Operating Cash Flow increased to 203 million in 2024Q3 from 126 million in 2024Q2 representing a change of 61.19%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 126 million in 2024Q3 from 60 million in 2024Q2 representing a change of 110.48%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure decreased to -77 million in 2024Q3 from -66 million in 2024Q2 representing a change of -16.24%. This indicates a possible improved efficiency or a shift in the company's strategic priorities.
Stock-Based Compensation: Stock-Based Compensation decreased to 15 million in 2024Q3 from 19 million in 2024Q2 representing a change of -20.11%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables decreased to 4 million in 2024Q3 from 25 million in 2024Q2 representing a change of -117.13%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Dividends Paid: Dividends Paid increased to 0 million in 2024Q3 from -19 million in 2024Q2 representing a change of 100.0%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q3 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2023-12-31 | 2022-12-31 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 3.91 | 3.93 | -0.50 |
| net income per share | -1.36 | -5.86 | 76.84 |
| operating cash flow per share | 1.11 | 0.75 | 47.10 |
| free cash flow per share | 0.75 | 0.45 | 64.84 |
| cash per share | 0.56 | 0.52 | 7.47 |
| book value per share | 8.92 | 10.08 | -11.45 |
| tangible book value per share | -7.5 | -8.14 | 7.81 |
| shareholders equity per share | 8.92 | 10.08 | -11.45 |
| interest debt per share | 7.5 | 7.95 | -5.62 |
| market cap | 6219016000 | 5638674000 | 10.29 |
| enterprise value | 10657016000 | 10394474000 | 2.53 |
| pe ratio | -6.83 | -1.42 | -379.34 |
| price to sales ratio | 2.37 | 2.12 | 11.59 |
| pocfratio | 8.36 | 11.07 | -24.52 |
| pfcf ratio | 12.4 | 18.4 | -32.64 |
| pb ratio | 1.04 | 0.83 | 25.39 |
| ptb ratio | 1.04 | 0.83 | 25.39 |
| ev to sales | 4.05 | 3.91 | 3.73 |
| enterprise value over ebitda | -124.06 | 7.99 | -1,652.45 |
| ev to operating cash flow | 14.32 | 20.41 | -29.84 |
| ev to free cash flow | 21.24 | 33.92 | -37.39 |
| earnings yield | -0.15 | -0.7 | 79.14 |
| free cash flow yield | 0.08 | 0.05 | 48.46 |
| debt to equity | 0.79 | 0.75 | 5.69 |
| debt to assets | 0.37 | 0.37 | 2.02 |
| net debt to ebitda | -51.66 | 3.66 | -1,513.02 |
| current ratio | 0.91 | 0.89 | 2.17 |
| interest coverage | -2.5 | -14.52 | 82.78 |
| income quality | -0.82 | -0.13 | -535.07 |
| dividend yield | 0.01 | 0.01 | -9.21 |
| payout ratio | -0.08 | -0.02 | -335.19 |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.87 | 0.88 | -1.70 |
| capex to operating cash flow | 0.33 | 0.4 | -18.21 |
| capex to revenue | 0.09 | 0.08 | 20.93 |
| capex to depreciation | 0.34 | 0.29 | 19.89 |
| stock based compensation to revenue | 0.04 | 0.04 | 17.45 |
| graham number | 16.5 | 36.44 | -54.71 |
| roic | -0.06 | -0.33 | 81.17 |
| return on tangible assets | -0.54 | -2.43 | 77.62 |
| graham net net | -8.49 | -8.99 | 5.55 |
| working capital | -137800000 | -164600000 | 16.28 |
| tangible asset value | -5038000000 | -5501700000 | 8.43 |
| net current asset value | -5252300000 | -5737200000 | 8.45 |
| invested capital | 10999300000 | 12263000000 | -10.30 |
| average receivables | 890200000 | 872100000 | 2.08 |
| average payables | 122750000 | 101400000 | 21.06 |
| average inventory | 4450000 | 97400000 | -95.43 |
| days sales outstanding | 126.11 | 119.68 | 5.38 |
| days payables outstanding | 58.03 | 38.8 | 49.57 |
| days of inventory on hand | -35.64 | 37.27 | -195.63 |
| receivables turnover | 2.89 | 3.05 | -5.10 |
| payables turnover | 6.29 | 9.41 | -33.14 |
| inventory turnover | -10.24 | 9.79 | -204.57 |
| roe | -0.15 | -0.58 | 73.84 |
| capex per share | 0.36 | 0.3 | 20.32 |
ROE: Return on Equity (ROE) increased to -0.15 on 2023-12-31 from -0.58 on 2022-12-31, representing a change of 73.84%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -6.83 on 2023-12-31 from -1.42 on 2022-12-31, representing a change of -379.34%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio increased to 0.91 on 2023-12-31 from 0.89 on 2022-12-31, representing a change of 2.17%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. However, it's below 1, indicating potential liquidity issues.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.79 on 2023-12-31 from 0.75 on 2022-12-31, representing a change of 5.69%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
| 2024-09-30 Q3 | 2024-06-30 Q2 | Q/Q change % | |
|---|---|---|---|
| CLVT | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 0.87 | 0.95 | -8.73 |
| net income per share | -0.09 | -0.44 | 79.44 |
| operating cash flow per share | 0.28 | 0.18 | 53.77 |
| free cash flow per share | 0.18 | 0.09 | 100.79 |
| cash per share | 0.54 | 0.55 | -1.54 |
| book value per share | 7.67 | 8.17 | -6.16 |
| tangible book value per share | -6.89 | -7.15 | 3.70 |
| shareholders equity per share | 7.67 | 8.17 | -6.16 |
| interest debt per share | 6.61 | 6.93 | -4.66 |
| market cap | 5102770000 | 3791368000 | 34.59 |
| enterprise value | 9426770000 | 8146268000 | 15.72 |
| pe ratio | -19.45 | -3.11 | -524.32 |
| price to sales ratio | 8.2 | 5.83 | 40.67 |
| pocfratio | 25.12 | 30.09 | -16.50 |
| pfcf ratio | 40.34 | 63.08 | -36.06 |
| pb ratio | 0.93 | 0.68 | 36.81 |
| ptb ratio | 0.93 | 0.68 | 36.81 |
| ev to sales | 15.15 | 12.53 | 20.95 |
| enterprise value over ebitda | 47.39 | 32.39 | 46.32 |
| ev to operating cash flow | 46.41 | 64.65 | -28.21 |
| ev to free cash flow | 74.52 | 135.55 | -45.02 |
| earnings yield | -0.01 | -0.08 | 83.98 |
| free cash flow yield | 0.02 | 0.02 | 56.39 |
| debt to equity | 0.85 | 0.84 | 1.57 |
| debt to assets | 0.39 | 0.39 | 0.31 |
| net debt to ebitda | 21.74 | 17.32 | 25.55 |
| current ratio | 0.88 | 0.9 | -2.34 |
| interest coverage | 0.3 | 0.94 | -68.15 |
| income quality | -3.1 | -0.41 | -647.72 |
| dividend yield | 0 | 0.0 | -100.00 |
| payout ratio | 0 | -0.06 | 100.00 |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0.87 | 0.87 | -0.03 |
| capex to operating cash flow | 0.38 | 0.52 | -27.89 |
| capex to revenue | 0.12 | 0.1 | 21.49 |
| capex to depreciation | 0.43 | 0.36 | 20.96 |
| stock based compensation to revenue | 0.02 | 0.03 | -16.50 |
| graham number | 3.97 | 9.04 | -56.07 |
| roic | 0.0 | 0.01 | -56.65 |
| return on tangible assets | -0.04 | -0.19 | 78.40 |
| graham net net | -7.72 | -8.02 | 3.73 |
| working capital | -186500000 | -150300000 | -24.09 |
| tangible asset value | -4950000000 | -4903200000 | -0.95 |
| net current asset value | -5178000000 | -5138300000 | -0.77 |
| invested capital | 10382400000 | 10451700000 | -0.66 |
| average receivables | 784050000 | 809600000 | -3.16 |
| average payables | 127300000 | 115400000 | 10.31 |
| average inventory | 0 | 69100000 | -100.00 |
| days sales outstanding | 111.64 | 110.21 | 1.30 |
| days payables outstanding | 54.19 | 28.97 | 87.07 |
| days of inventory on hand | 0 | 0 | NaN |
| receivables turnover | 0.81 | 0.82 | -1.28 |
| payables turnover | 1.66 | 3.11 | -46.54 |
| inventory turnover | 0 | 0 | NaN |
| roe | -0.01 | -0.05 | 78.09 |
| capex per share | 0.11 | 0.1 | 10.88 |
ROE: Return on Equity (ROE) increased to -0.01 on 2024-09-30 Q3 from -0.05 on 2024-06-30 Q2, representing a change of 78.09%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to -19.45 on 2024-09-30 Q3 from -3.11 on 2024-06-30 Q2, representing a change of -524.32%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 0.88 on 2024-09-30 Q3 from 0.90 on 2024-06-30 Q2, representing a change of -2.34%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.
Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.85 on 2024-09-30 Q3 from 0.84 on 2024-06-30 Q2, representing a change of 1.57%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
None
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-13 03:00:00
Recognizing Roper St. Francis Healthcare, Bon Secours Mercy Health, and Bronson Methodist Hospital for excellence in Physician and Hospital Groups LONDON , Nov. 13, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, announced the 2023 winners of the Clarivate Healthcare Business Insights™ annual Revenue Cycle Awards. Now in its 12th year, the Revenue Cycle Awards recognize U.S.-based healthcare organizations for exceptional performance on revenue cycle KPIs, based on data from their most recent and preceding full fiscal years.
Sentiment: Positive
Publish Date: 2024-11-12 03:00:00
LONDON , Nov. 12, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has today published its fourth annual sustainability report, showcasing its commitment to sustainability and the United Nations Sustainable Development Goals (SDGs). In 2023, Clarivate was shortlisted for the SDG Pioneer Award at the Thomson Reuters Responsible Business Awards.
Sentiment: Neutral
Publish Date: 2024-11-08 08:04:35
I downgrade Clarivate PLC from buy to hold due to lack of confidence in near-term organic growth recovery and potential further stock price decline. CLVT's 3Q24 earnings report showed a 3.9% revenue decline and worsening organic growth, marking the worst performance in its history. The new CEO's Value Creation Plan is promising but will take a long time to show results, adding to the uncertainty.
Sentiment: Positive
Publish Date: 2024-11-07 03:00:00
ProQuest One Sustainability offers a transdisciplinary research experience and features AI-powered ProQuest Research Assistant LONDON , Nov. 7, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the launch of ProQuestTM One Sustainability. The new solution is an expansive, curated, multi-format content collection designed to meet the growing demand for sustainability curricula across research, teaching and learning.
Sentiment: Positive
Publish Date: 2024-11-06 15:07:46
Clarivate Plc (NYSE:CLVT ) Q3 2024 Earnings Conference Call November 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Matti Shem Tov - Chief Executive Officer Jonathan Collins - Chief Financial Officer Conference Call Participants Owen Lau - Oppenheimer David Paige - RBC Toni Kaplan - Morgan Stanley Andrew Nicholas - William Blair Manav Patnaik - Barclays Shlomo Rosenbaum - Stifel Peter Christiansen - Citi George Tong - Goldman Sachs Colton Feldmann - Jefferies Operator Hello, and thank you for standing by. My name is Regina and I will be your conference operator today.
Sentiment: Positive
Publish Date: 2024-11-06 10:35:47
The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Sentiment: Positive
Publish Date: 2024-11-06 08:10:22
Clarivate PLC (CLVT) came out with quarterly earnings of $0.19 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.21 per share a year ago.
Sentiment: Positive
Publish Date: 2024-11-06 06:00:00
LONDON , Nov. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the third quarter ended September 30, 2024. Third  Quarter 2024 Financial Highlights Revenues of $622.2 million decreased 3.9% Organic revenues decreased 2.6%, as an increase in subscription revenues of 0.6% was offset by a decrease in re-occurring revenues of 1.1% and transactional and other revenues of 13.6% Net loss of $65.6 million; Net loss per diluted share of $0.09 Adjusted net income(1) of $134.1 million decreased 12.1%; Adjusted diluted EPS(1) of $0.19 decreased 9.5% or $0.02 Adjusted EBITDA(1) of $264.4 million decreased 6.0%; Adjusted EBITDA margin(1) of 42.5% decreased 100 basis points primarily due to lower revenues Net cash provided by operating activities of $202.9 million increased $39.5 million; Free cash flow(1) of $126.3 million increased $24.6 million primarily due to the timing of working capital Nine Months Ended September 30, 2024 Financial Highlights Revenues of $1,893.7 million decreased 2.6% Organic revenues decreased 1.5% as an increase in subscription revenues of 1.2% was offset by a decline in re-occurring revenues of 2.3% and transactional and other revenues of 9.3% Net loss of $444.9 million; Net loss per diluted share of $0.69 Adjusted net income(1) of $379.8 million decreased 12.8%; Adjusted diluted EPS(1) of $0.52 decreased 11.9% or $0.07 Adjusted EBITDA(1) of $775.1 million decreased 5.4%; Adjusted EBITDA margin(1) of 40.9% decreased 120 basis points primarily due to lower revenues Net cash provided by operating activities decreased $48.0 million to $505.3 million; Free cash flow(1) decreased $76.3 million to $298.4 million primarily due to lower operating income and increased capital expenditures "Clarivate's third quarter results are unsatisfactory and reflect an overdependency on fluctuating transactional revenue and areas of the business with low margin characteristics," said Matti Shem Tov, Chief Executive Officer.
Sentiment: Positive
Publish Date: 2024-11-05 10:20:42
Get a deeper insight into the potential performance of Clarivate (CLVT) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Sentiment: Positive
Publish Date: 2024-10-30 11:06:49
Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment: Positive
Publish Date: 2024-10-29 06:30:00
ST. LOUIS--(BUSINESS WIRE)--Silverchair, a portfolio company of Thompson Street Capital Partners (TSCP), announced today that is has entered into a definitive agreement with Clarivate Plc (NYSE:CLVT) to acquire ScholarOne, a leading provider of software and services to scholarly publishers and societies. Terms of the transaction were not disclosed. Founded in 1993 and based in Charlottesville, VA, Silverchair provides a suite of software and services to leading global publishers of scientific,.
Sentiment: Positive
Publish Date: 2024-10-16 08:30:00
LONDON , Oct. 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the third quarter 2024 before the market opens on Wednesday, November 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
Sentiment: Positive
Publish Date: 2024-10-15 03:00:00
83 Citation Laureates named by the Institute for Scientific Information have received a Nobel Prize since 2002 LONDON , Oct. 15, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the success of its annual Citation Laureates™ program, following the accurate forecast of eight Nobel Prize 2024 recipients. Powered by trusted, high-quality data from the Web of Science Core Collection™ citation index, the Citation Laureates program combines rigorous citation analysis with expert qualitative insights to pinpoint researchers with exceptional citation records who have the potential to receive Nobel honors.
Sentiment: Positive
Publish Date: 2024-10-04 03:00:00
Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in Latin America at premier Life Sciences event LONDON , Oct. 4, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 2nd annual Summit LATAM, which will be held in Milan on October 7, 2024, ahead of the CPHI Milan conference. In partnership with the Brazilian Association of the Pharmaceutical Ingredients Industry (Abiquifi), this year's event reinforces the industry's commitment to patient welfare by showcasing how collective efforts and innovative strategies are reshaping the pharmaceutical ecosystem, with a focus on navigating market challenges and uncovering innovation opportunities.
Sentiment: Positive
Publish Date: 2024-09-25 03:00:00
LONDON , Sept. 25, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced the development of a comprehensive framework for evaluating the societal impact of research.
Sentiment: Positive
Publish Date: 2024-09-24 03:00:00
Sharing benchmarks and strategies to elevate IP practices LONDON , Sept. 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released a new survey-based report that reveals insights and best practices for optimizing intellectual property (IP) operations.
Sentiment: Positive
Publish Date: 2024-09-23 03:00:00
Clarivate Medtech Intelligence and Relatable software enhance product data management and competitive conversion efficiency for medtech sales, contracting and pricing teams LONDON , Sept. 23, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Relatable Healthcare, a technology company delivering Product Relationship Management (PRM) software to leading medtech companies to drive revenue and workflow efficiency.
Sentiment: Positive
Publish Date: 2024-09-19 03:00:00
Annual recognition highlights researchers with extraordinary citation records and societal impact, poised for Nobel recognition LONDON , Sept. 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today unveiled the Citation Laureates™ 2024 list – used to forecast future Nobel Prize recipients.
Sentiment: Positive
Publish Date: 2024-09-18 03:00:00
Transforming library discovery with Academic AI that provides users a new and easy way to find trusted content LONDON , Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched Primo™ Research Assistant.
Sentiment: Positive
Publish Date: 2024-09-18 03:00:00
Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON , Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 15th annual Clarivate Pharmavision India conference.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
